News

Researchers at the University of Maryland School of Medicine Invent Software Fueled by Genomics into Mathematical Models to Predict Cancer Cell Behavior

In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a “master regulator” gene, ZNFX1, that may act as a biomarker to help guide treatment in future clinical trials involving patients with therapy-resistant ovarian cancer, according to a study recently published in Cancer Research.

The University of Maryland School of Medicine (UMSOM) is pleased to welcome Wei Li, PhD, who has been appointed Associate Professor of Pharmacology and Physiology at UMSOM. Dr. Li is an expert in computational biology and CRISPR-mediated gene editing who comes to UMSOM from George Washington University.

Data collected in pre-treatment CT-scans may provide important imaging biomarkers to better predict patient prognosis, and potentially customize treatment strategies

Taofeek K. Owonikoko, MD, PhD, Executive Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), has been named one of the 25 Black Marylanders to Watch for 2025 by The Baltimore Sun.

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) Executive Director, Taofeek K. Owonikoko, MD, PhD, and University of Maryland School of Medicine (UMSOM) Department of Surgery Chair, Christine Lau, MD, MBA, have announced that Jeremy L. Davis, MD, will serve as the new Surgical Oncology Lead for UMGCCC and Chief of the Division of Surgical Oncology in the Department of Surgery at UMSOM. Dr. Davis is a nationally recognized surgical oncologist and leader in gastric cancer research.